| Year |
Citation |
Score |
| 2020 |
Aubrey KR, Sheipouri D, Balle T, Vandenberg RJ, Otsu Y. Glutamate, AP5 and NMDA do not directly modulate glycine receptors. Molecular Pharmacology. PMID 33051383 DOI: 10.1124/molpharm.120.000127 |
0.611 |
|
| 2018 |
Aubrey KR, Supplisson S. Heterogeneous Signaling at GABA and Glycine Co-releasing Terminals. Frontiers in Synaptic Neuroscience. 10: 40. PMID 30524262 DOI: 10.3389/Fnsyn.2018.00040 |
0.747 |
|
| 2016 |
Aubrey KR, Drew GM, Jeong HJ, Lau BK, Vaughan CW. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses. The Journal of Physiology. PMID 27461371 DOI: 10.1113/Jp272292 |
0.419 |
|
| 2016 |
Aubrey KR. Presynaptic control of inhibitory neurotransmitter content in VIAAT containing synaptic vesicles. Neurochemistry International. PMID 27296116 DOI: 10.1016/J.Neuint.2016.06.002 |
0.588 |
|
| 2013 |
Wang L, Tu P, Bonet L, Aubrey KR, Supplisson S. Cytosolic transmitter concentration regulates vesicle cycling at hippocampal GABAergic terminals. Neuron. 80: 143-58. PMID 24094108 DOI: 10.1016/J.Neuron.2013.07.021 |
0.715 |
|
| 2008 |
Rousseau F, Aubrey KR, Supplisson S. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9755-68. PMID 18815261 DOI: 10.1523/Jneurosci.0509-08.2008 |
0.782 |
|
| 2008 |
Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochemical Pharmacology. 76: 1014-23. PMID 18755158 DOI: 10.1016/J.Bcp.2008.07.037 |
0.539 |
|
| 2007 |
Aubrey KR, Rossi FM, Ruivo R, Alboni S, Bellenchi GC, Le Goff A, Gasnier B, Supplisson S. The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6273-81. PMID 17554001 DOI: 10.1523/Jneurosci.1024-07.2007 |
0.772 |
|
| 2006 |
Wiles AL, Pearlman RJ, Rosvall M, Aubrey KR, Vandenberg RJ. N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. Journal of Neurochemistry. 99: 781-6. PMID 16899062 DOI: 10.1111/J.1471-4159.2006.04107.X |
0.608 |
|
| 2006 |
Supplisson S, Rousseau F, Roux MJ, Rossi FM, Aubrey KR. Glycine transporters: Structural insights from biophysics, physiology and human disease Acta Biomedica De L'Ateneo Parmense. 77: 38-39. |
0.7 |
|
| 2005 |
Aubrey KR, Vandenberg RJ, Clements JD. Dynamics of forward and reverse transport by the glial glycine transporter, glyt1b. Biophysical Journal. 89: 1657-68. PMID 15951392 DOI: 10.1529/Biophysj.105.061572 |
0.718 |
|
| 2004 |
Vandenberg RJ, Ju P, Aubrey KR, Ryan RM, Mitrovic AD. Allosteric modulation of neurotransmitter transporters at excitatory synapses. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 23: 1-11. PMID 15324920 DOI: 10.1016/J.Ejps.2004.05.006 |
0.719 |
|
| 2004 |
Ju P, Aubrey KR, Vandenberg RJ. Zn2+ inhibits glycine transport by glycine transporter subtype 1b. The Journal of Biological Chemistry. 279: 22983-91. PMID 15031290 DOI: 10.1074/Jbc.M312484200 |
0.715 |
|
| 2003 |
Pearlman RJ, Aubrey KR, Vandenberg RJ. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. Journal of Neurochemistry. 84: 592-601. PMID 12558979 DOI: 10.1046/J.1471-4159.2003.01549.X |
0.697 |
|
| 2001 |
Vandenberg RJ, Aubrey KR. Glycine transport inhibitors as potential antipsychotic drugs. Expert Opinion On Therapeutic Targets. 5: 507-518. PMID 12540263 DOI: 10.1517/14728222.5.4.507 |
0.638 |
|
| 2001 |
Aubrey KR, Vandenberg RJ. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. British Journal of Pharmacology. 134: 1429-36. PMID 11724748 DOI: 10.1038/Sj.Bjp.0704381 |
0.708 |
|
| 2001 |
Vandenberg RJ, Aubrey KR. Central and peripheral nervous system: Glycine transport inhibitors as potential antipsychotic drugs Expert Opinion On Therapeutic Targets. 5: 507-518. |
0.585 |
|
| 2000 |
Aubrey KR, Mitrovic AD, Vandenberg RJ. Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b. Molecular Pharmacology. 58: 129-35. PMID 10860934 DOI: 10.1124/Mol.58.1.129 |
0.71 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Otsu Y, Aubrey KR. Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord. The Journal of Physiology. PMID 35979937 DOI: 10.1113/JP283021 |
0.251 |
|
| 2023 |
Assareh N, Fenech C, Power R, Uddin MN, Otsu Y, Aubrey KR. Bidirectional modulation of nociception by GlyT2 neurons in the ventrolateral periaqueductal gray. Eneuro. PMID 37253591 DOI: 10.1523/ENEURO.0069-23.2023 |
0.195 |
|
| 2019 |
Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet (London, England). 393: 1537-1546. PMID 30983589 DOI: 10.1016/S0140-6736(19)30352-6 |
0.177 |
|
| 2022 |
Natale C, Christie MJ, Aubrey KR. Spinal glycinergic currents are reduced in a rat model of neuropathic pain following partial nerve ligation but not chronic constriction injury. Journal of Neurophysiology. PMID 36541621 DOI: 10.1152/jn.00451.2022 |
0.137 |
|
| 2023 |
Sokolaj E, Assareh N, Anderson K, Aubrey KR, Vaughan CW. Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence. Journal of Neurochemistry. PMID 37747128 DOI: 10.1111/jnc.15964 |
0.074 |
|
| 2022 |
Glare P, Aubrey K, Gulati A, Lee YC, Moryl N, Overton S. Pharmacologic Management of Persistent Pain in Cancer Survivors. Drugs. PMID 35175587 DOI: 10.1007/s40265-022-01675-6 |
0.032 |
|
| 2020 |
Glare P, Overton S, Aubrey K. Transition from acute to chronic pain: where cells, systems and society meet. Pain Management. 10: 421-436. PMID 33111634 DOI: 10.2217/pmt-2019-0039 |
0.031 |
|
| Hide low-probability matches. |